Evidence map›Paper›PMID 35612841›Full record

ArticleArchives of endocrinology and metabolism2022

Non-alpine primary thyroid angiosarcoma.

Nádia Mourinho Bala, Pedro Simões, José Maria Aragüés, Ricardo Veiga, Sílvia Guerra, Cristina Valadas

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Archives of endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nádia Mourinho BalaDepartamento de Endocrinologia, Hospital Beatriz Ângelo, Loures, Portugal, nadia.bala@hbeatrizangelo.pt.ORCID 0000-0002-5834-4848
Pedro SimõesDepartamento de Oncologia, Hospital Beatriz Ângelo, Loures, Portugal.ORCID 0000-0002-4734-7621
José Maria AragüésDepartamento de Endocrinologia, Hospital Beatriz Ângelo, Loures, Portugal.ORCID 0000-0003-0711-277X
Ricardo VeigaDepartamento de Patologia, Hospital Beatriz Ângelo, Loures, Portugal.ORCID 0000-0001-6188-4709
Sílvia GuerraDepartamento de Endocrinologia, Hospital Beatriz Ângelo, Loures, Portugal.ORCID 0000-0002-1969-2487
Cristina ValadasDepartamento de Endocrinologia, Hospital Beatriz Ângelo, Loures, Portugal.ORCID 0000-0002-2368-4447
Hospital Beatriz Ângelo · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid angiosarcoma is an extremely rare malignancy, which occurs more frequently in the alpine region, likely associated with iodine deficiency and endemic goiter. This is an aggressive neoplasm that usually harbors a poor prognosis. We report the case of a 49-year-old Portuguese female patient presenting with a large nodule in the anterior neck region, with rapid growth and associated dysphonia. The neck ultrasound showed a hypoechogenic and heterogeneous thyroid nodule, with a larger axis of 44 mm. The fine needle aspiration cytology was not conclusive, and a biopsy of the lesion was performed. The result was suggestive of a mesenchymal tumor constituted by spindle cells and vascular clefts, showing positivity for endothelial markers and negativity for thyroglobulin, calcitonin and TTF1. The chest CT scan performed before surgery showed multiple pulmonary nodules suggestive of secondary lesions. The patient was submitted to total thyroidectomy and lymph node dissection in order to relieve compressive symptoms. A diagnosis of thyroid angiosarcoma was made after histologic examination of the surgical specimen. Despite undergoing multiple lines of palliative chemotherapy, the pulmonary lesions increased in size and number. The patient died due to respiratory failure 29 months after the diagnosis. Thyroid angiosarcoma is a rare malignancy, generally with poor prognosis. In our case, the patient presented with pulmonary metastases at diagnosis, which is a negative prognostic factor. Due to its rarity, data regarding management and treatment of this disease are scarce.

Indexed as

HemangiosarcomaThyroid NeoplasmsFatal OutcomeFemaleHumansLung NeoplasmsMiddle AgedThyroidectomy

Identifiers

PMID35612841
PMCPMC9832846
OpenAlexW4281876399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.